Reductive activation of the bifunctional alkylator and DNA
cross-linking agent mitomycin C (MC) yields
2,7-diaminomitosene (2,7-DAM) as the major product of its activation
both in cell-free systems and in vivo. 2,7-DAM lacks one of the alkylating functions of MC, the aziridine. We
show that 2,7-DAM itself alkylates DNA
monofunctionally upon reductive activation, to form a heat-labile
adduct. A guanine-N7−2,7-DAM adduct was
isolated from the drug−DNA complex upon heating. Nuclease
digestion yielded this adduct both in the nucleoside
(dG-2,7-DAM) and dinucleoside phosphate [d(GpG)-2,7-DAM] forms.
The structures of all three forms were
determined by LC−ESIMS and differential UV spectroscopy. The
adduct is sequence-specific to guanines in
(G)
n
tracts of DNA. A guanine-N7−2,7-DAM adduct in DNA was indirectly
observed previously by Prakash et al.
(Prakash, A. S.; Beall, H.; Ross, D.; Gibson, N. W.
Biochemistry
1993, 32, 5518−5525).
The results indicate that
selective removal of the aziridine function of MC results in a switch
from minor to major groove alkylation of DNA,
and a switch of sequence specificity from guanines in CpG to guanines
in (G)
n
tracts. They also show that
the
mitosene C-10 carbamate intrinsically reacts as an SN2
alkylating agent, specific to guanine-N7.